Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ACSL1 | P33121 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.33 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9752005 | 0.80 | MAOA (0.42) | NISCHGABRA1GABRB2MAOAMAOB | |
| SCHEMBL9751996 | 0.78 | NISCH (0.53) | NISCHGABRA1GABRB2MAOAMAOB | |
| SCHEMBL10400768 | 0.77 | MAOA (0.39) | NISCHGABRA1GABRB2MAOAMAOB | |
| SCHEMBL10400577 | 0.77 | ALDH1A1 (0.47) | SMN1; SMN2TDP1TSHRALDH1A1MEN1 | |
| SCHEMBL9753155 | 0.77 | MAOA (0.39) | NISCHGABRA1GABRB2MAOAMAOB | |
| SCHEMBL10400578 | 0.75 | ACSL1 (0.40) | NISCHSMN1; SMN2GABRA1GABRB2MAOA | |
| SCHEMBL9752907 | 0.74 | ALDH1A1 (0.41) | NISCHSMN1; SMN2MAOAMAOBTDP1 | |
| SCHEMBL9752721 | 0.73 | MAOA (0.45) | NISCHSMN1; SMN2GABRA1GABRB2MAOA | |
| Potassium Ion SCHEMBL9752861 | 0.73 | MAOA (0.45) | NISCHSMN1; SMN2GABRA1GABRB2MAOA | |
| SCHEMBL10400814 | 0.73 | TSHR (0.43) | NISCHGABRA1GABRB2MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3060043-B1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | CORTEVA AGRISCIENCE LLC (US) | 2025-11-26 | — | — | EP | claimed |
| US-12098150-B2 | Crystal of heterocyclic amide compound and method for producing same | NISSAN CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| EP-3939977-B1 | CRYSTAL OF HETEROCYCLIC AMIDE COMPOUND AND METHOD FOR PRODUCING SAME | NISSAN CHEMICAL CORP (JP) | 2024-05-08 | — | — | EP | disclosed |
| WO-2024038801-A1 | AQUEOUS SUSPENSION-TYPE AGROCHEMICAL COMPOSITION | 日産化学株式会社 | 2024-02-22 | — | — | WO | disclosed |
| US-20220153736-A1 | CRYSTAL OF HETEROCYCLIC AMIDE COMPOUND AND METHOD FOR PRODUCING SAME | NISSAN CHEMICAL CORPORATION (JP) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153736-A1 | CRYSTAL OF HETEROCYCLIC AMIDE COMPOUND AND METHOD FOR PRODUCING SAME | DDT, HDHD5, AADAC | NISCH 166/4885SMN1; SMN2 4530/4885GABRA1 3436/4885 |
| US-12098150-B2 | Crystal of heterocyclic amide compound and method for producing same | DDT, HDHD5, AADAC | NISCH 166/4885SMN1; SMN2 4530/4885GABRA1 3436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.